共 244 条
[11]
Barsness GW(2010)Copeptin improves early diagnosis of acute myocardial infarction J Am Coll Cardiol 55 110-827
[12]
Beatty AL(2018)Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes Cardiovasc Diabetol 17 823-1759
[13]
Deedwania PC(2013)Brain natriuretic peptide and copeptin levels are associated with cardiovascular disease in patients with chronic kidney disease Chin Med J (Engl) 126 1750-27
[14]
Inzucchi SE(2013)Copeptin and cardiovascular disease: a review of a novel neurohormone Int J Cardiol 167 18-1691
[15]
Jia S(2014)Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis Eur Heart J Acute Cardiovasc Care 3 1690-1558
[16]
Liu Y(1998)What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes JAMA 280 1539-634
[17]
Yuan J(2002)Quantifying heterogeneity in a meta-analysis Stat Med 21 629-2110
[18]
Safiri S(1997)Bias in meta-analysis detected by a simple, graphical test BMJ 315 2103-1194
[19]
Karamzad N(2007)C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study Circulation 115 1187-1606
[20]
Singh K(2009)C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study Eur Heart J 30 1604-89